Prof Lindeman's laboratory, co-headed with Dr Visvader, has played an influential role in the identification of mammary stem and progenitor cells, elucidation of the mammary epithelial cell hierarchy and gaining insights into how female hormones regulate mammary gland development and cancer. In parallel, I have established translational research platforms such as patient-derived tumour xenograft (PDX) models, which offer powerful preclinical models to test new drugs.
Fellowship Application, Ed Stanley: Pluripotent Stem Cells & Medical Research
Funder
National Health and Medical Research Council
Funding Amount
$638,517.00
Summary
Human Pluripotent Stem Cells are immortal cells that have the ability to turn into any of the cell types found in the body. This means that it is now possible to generate a variety of human cell types in the laboratory, to study how they work, and to find out what goes wrong in different diseases. In this context, the overall aim of my research is to develop pluripotent stem cells for the study of human disease and generate tools that will enable others to use these cells in their own research.
Stem Cell Niches: Biology And Therapeutic Applications
Funder
National Health and Medical Research Council
Funding Amount
$640,210.00
Summary
This research aims to identify how stem cells are regulated in the body in order to improve therapies for blood disorders and abnormal bone formation after severe traumas. Targeting molecules that deregulate stem cells will lead to improved treatments for diseases with outcomes including improved treatments for blood stem cell transplantation, improved therapy in cancer patients and reduced complications of spinal cord injuries.
Preventing Infectious Disease In Vulnerable Populations: Smarter Surveillance, Enhanced Epidemiology And Targeted Trials
Funder
National Health and Medical Research Council
Funding Amount
$631,010.00
Summary
Vulnerable populations, including people who inject drugs and female sex workers, are susceptible to infectious diseases such as HIV and hepatitis C. Preventing the transmission of these infections presents major challenges. The proposed research will 1) develop innovative approaches to identifying and understanding infectious disease in vulnerable populations; 2) improve our responses by designing and testing new approaches to prevention; and 3) reduce associated morbidity and mortality.
Understanding And Overcoming Cardiovascular And Diabetes Inequalities In Indigenous Australians
Funder
National Health and Medical Research Council
Funding Amount
$707,370.00
Summary
Aboriginal and Torres Strait Islanders experience the highest rates of heart disease and diabetes of all Australians. The reasons for this large disparity is not yet fully understood. I propose to investigate the patterns, causes, complications and links between heart disease and diabetes in Indigenous populations to identify better ways of managing and preventing chronic disease in high risk communities.
Discovery And Development Of Novel Venom Peptide Analgesics
Funder
National Health and Medical Research Council
Funding Amount
$763,845.00
Summary
Professor Lewis will discover and develop new research tools and potential therapeutics from toxins acting on pain pathways. The Fellowship will leverage (i) well-funded collaborations with top Australian and international scientists (ii) the recently established IMB Centre for Pain Research that I lead as inaugural Director, and (iii) an outstanding Institute equipped with leading edge technologies for high throughput and high content discovery and proteomic and transcriptomic analysis.
Regenerating The Kidney Using An Understanding Of Normal Development
Funder
National Health and Medical Research Council
Funding Amount
$951,005.00
Summary
In Australia, chronic kidney disease costs >$1 billion per annum, however treatment options for kidney failure have not changed for >50 years. Dialysis reduces quality of life and lifespan while only 1 in 4 patients receives a transplant. Using our understanding of normal kidney formation, this study will generate kidney tissue from human stem cells to better understand inherited kidney diseases and develop novel regenerative therapies for the treatment of end stage kidney disease.
Toll-like Receptors And Innate Immunity: Genes And Pathways Regulating Infectious And Inflammatory Diseases
Funder
National Health and Medical Research Council
Funding Amount
$138,367.00
Summary
The innate immune system is the first line of defence against infectious diseases, but also contributes to the pathology of inflammatory diseases (e.g. rheumatoid arthritis). I study specific genes and pathways used by the innate immune system to (1) understand how the innate immune system prevents infections and how microorganisms overcome these defences, and (2) develop approaches to block inflammation. Outcomes may include new therapies for inflammatory and infectious diseases.
My work investigates the neural output to human inspiratory muscles and how it is related to mechanical effectiveness for breathing. The aim is to discover how this relationship can change with respiratory disorders such as chronic obstructive pulmonary disease and obstructive sleep apnoea. I also examine the changes in breathing muscle control in people with spinal cord injury. This work promises new understanding of the basic control of respiration and how it changes with disease.
Understanding The Shared Determinants And Causal Pathways Of Early Life Infection, Inflammation And Atherosclerosis.
Funder
National Health and Medical Research Council
Funding Amount
$632,803.00
Summary
Infection is the commonest reason for childhood hospitalisation, but it is unknown why infection is much more severe in some children. The long-term effects of infection on the development of atherosclerosis (hardening of the arteries), the underlying cause of cardiovascular disease, is also unknown. This research investigates these important questions with the aim of developing better prediction and prevention of severe infection and reducing its impact on adult cardiovascular disease.